Product Program year 2025 Source: CMS Open Payments

Zephyr Endobronchial Valve

Device Pulmonology

PDI 00811907030126

Open in the dashboard

General payments

$3,242,169

17,406 payments

Research payments

$1,192,917

319 payments

Through program year 2025, $3,242,169 in general payments and $1,192,917 in research payments were reported against Zephyr Endobronchial Valve (Pulmonology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

9 rows
Year Kind Amount Payments
2025 General $966,295 5,514
2025 Research $84,339 35
2024 General $847,726 4,502
2024 Research $358,333 104
2023 General $639,271 3,789
2023 Research $475,304 108
2022 General $545,116 2,325
2022 Research $274,942 72
2021 General $243,763 1,276

Breakdown

Who paid General payments · program years 2021–2025
  1. Pulmonx Corporation $3,242,169 17,406 payments
Top recipients General payments · program year 2025
  1. Haley Hoy Nurse Practitioner, Acute Care · Nashville, TN $168,576 17% · 115 payments
  2. Amit Mahajan Internal Medicine · Falls Church, VA $137,026 14% · 94 payments
  3. Jonathan Kurman Pulmonary Disease · Milwaukee, WI $105,993 11% · 69 payments
  4. Henry Ford Hospital Teaching hospital · MI $25,000 3% · 2 payments
  5. Anil Magge Pulmonary Disease · Hartford, CT $21,190 2% · 24 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $406,092 44% · 1,209 practitioners
  2. Nurse Practitioner, Acute Care Nurse Practitioner $184,169 20% · 88 practitioners
  3. Internal Medicine $171,211 19% · 262 practitioners
  4. Critical Care Medicine Internal Medicine $37,279 4% · 167 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $29,675 3% · 306 practitioners

The top 5 of 75 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Tennessee $198,264 21% · 46 recipients
  2. Virginia $152,299 16% · 69 recipients
  3. Wisconsin $118,571 12% · 48 recipients
  4. Michigan $58,285 6% · 208 recipients
  5. Florida $57,019 6% · 447 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

17,406 general · 319 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record